Documentation Centre

 

 

  of 91 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391:541-551 May 10, 2018 Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391:541-551 Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S et al. Key Publications
Remission of type 2 diabetes: mission not impossible. Lancet. 2018;391:515-516 May 10, 2018 Remission of type 2 diabetes: mission not impossible. Lancet. 2018;391:515-516 Uusitupa M Key Publications
Comparison among criteria to define successful weight-loss maintainers and regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials. Am J Clin Nutr. 2017;106:1337-1346 April 30, 2018 Comparison among criteria to define successful weight-loss maintainers and regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials. Am J Clin Nutr. 2017;106:1337-1346 Berger SE, Huggins GS, McCaffery JM, Lichtenstein AH Key Publications
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391:319-328 April 27, 2018 Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391:319-328 Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ; CANTOS Trial Group Key Publications
Treatment concentration of high-sensitivity C-reactive protein. Lancet. 2018;391:287-289 April 26, 2018 Treatment concentration of high-sensitivity C-reactive protein. Lancet. 2018;391:287-289 Michos ED, Blumenthal RS Key Publications
Dyslipidaemias in 2017: Atherogenic lipoproteins as treatment targets. Nat Rev Cardiol. 2018;15:75-76 April 20, 2018 Dyslipidaemias in 2017: Atherogenic lipoproteins as treatment targets. Nat Rev Cardiol. 2018;15:75-76 Catapano AL Key Publications
Current pharmacotherapy for obesity. Nat Rev Endocrinol. 2018;14:12-24. April 10, 2018 Current pharmacotherapy for obesity. Nat Rev Endocrinol. 2018;14:12-24. Srivastava G, Apovian CM. Key Publications
Diabetes: Metformin - a cardiovascular moderator of DPP4 inhibitors? Nat Rev Endocrinol. 2018;14:8-9 April 09, 2018 Diabetes: Metformin - a cardiovascular moderator of DPP4 inhibitors? Nat Rev Endocrinol. 2018;14:8-9 Scheen AJ Key Publications
Sedentary behavior and compensatory mechanisms in response to different doses of exercise-a randomized controlled trial in overweight and obese adults. Eur J Clin Nutr. 2017;71:1393-1398 April 09, 2018 Sedentary behavior and compensatory mechanisms in response to different doses of exercise-a randomized controlled trial in overweight and obese adults. Eur J Clin Nutr. 2017;71:1393-1398 Castro EA, Júdice PB, Silva AM, Teixeira PJ, Benito PJ Key Publications
Is a DASH of salt all we need? J Am Coll Cardiol. 2017;70:2849-2851 April 04, 2018 Is a DASH of salt all we need? J Am Coll Cardiol. 2017;70:2849-2851 Wang TJ, Gupta DK Key Publications

  of 91 Next page

Go to page: of